New research co-led by the UAB School of Public Health could reshape treatment guidelines for asymptomatic carotid stenosis, a condition caused by a buildup of plaque in arteries that carry blood to the brain.

The Blazer Bridge Fund encourages discovery among the UAB community by providing financial support to innovative ideas and inventions.

Julius E. Linn Jr., M.D., who died Aug. 4, 2025, at age 84, devoted five decades of his professional life to advancing medical communication and preserving Alabama’s cultural heritage. His death marks the end of a remarkable career at The University of Alabama at Birmingham (UAB) that bridged the worlds of scientific research, medical publishing, and historical preservation.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

The understanding of how macrophages regulate their response to toxic particles via two independent pathways could uncover therapeutic opportunities to quell inflammation.

UAB is ranked No. 164 based on exceptional academic research portfolio and its overall global and regional reputation.

Results showed longer duration of hypertension is related to higher risk of stroke, higher average systolic blood pressure and a need for more classes of antihypertension medication.

The UAB REGARDS study, the cornerstone health disparities research in stroke and brain heath, has received another five years of funding from the NIH. 

This devastating neurodevelopmental disorder has no currently approved treatments.

UAB’s strategic planning continues to blaze its path to improve more lives by leveraging construction projects that include new and enhanced facilities across the institution, blooming green spaces and art installations.

The Center for Clinical and Translational Science based at the University of Alabama at Birmingham has been awarded four grants from the National Center for Advancing Translational Science, part of the National Institutes of Health, totaling $82 million over seven years.

With this collaborative effort, the profile of UAB within biomedical data science and future data-driven medicine will be significantly raised on a national stage.

Orlando Gutiérrez, M.D., will be appointed senior associate dean for Clinical and Translational Research in the UAB Marnix E. Heersink School of Medicine and director and contact principal investigator of the UAB Center for Clinical and Translational Science.

A new artificial intelligence center will bring more discovery in the field to UAB.

The program seeks to support and foster multidisciplinary collaborations, especially between UAB clinicians and basic and physician scientists.

Cooper recently won the Albert Lasker Award, known as “America’s Nobel Prize,” given to the living person considered to have made the greatest contribution to medical science.

The MyLupus app is a patient-friendly, patient-focused decision-aid tool for people from all backgrounds with moderate to severe lupus.

Results from the Chronic Hypertension and Pregnancy trial found treating preexisting mild chronic hypertension in pregnant women is safe from both the mom and baby. Results published in April 2022 have since led to changes in national guidelines.

These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.

The UAB projects will investigate was to improve and increase the use of artificial intelligence in biomedical research.